the effectievness and safety of intermittent fasting diet and GLP-1RA intervention on young and middle aged indivduals with obesity

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025424

Enrollment

Unknown

Registered

2019-08-26

Start date

2019-08-28

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

A:diet and exercise advice

B:intermittent fasting diet

C:GLP-1RA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 60 years; 2) BMI>=28kg/M2; 3) Understand and sign the informed consent; 4) Able to cooperate with diet or intramuscular injection treatment and evaluation.

Exclusion criteria

Exclusion criteria: 1) diabetes; 2)endocrine disease induced obesity (hypercortisolism, hypothyriodism, etc.); 3) Significant abnormalities in heart, lung, liver and kidney; 4) Participate in other clinical studies during the same period; 5) Pregnant and lactating women; 6) medullary thyroid carcinoma or family history; 7) tumor history; 8) take weight-loss drug within 3 months.

Design outcomes

Primary

Measure	Time frame
BMI;waist circumference;obedience;	—

Secondary

Measure	Time frame
HOMA-ISI;HOMA-IR;TG;LDL-C;blood pressure;body fat mass;	—

Countries

China

Contacts

Public ContactYin Xiao

Shandong University Affiliated Jinan Central Hospital

yinxiao@sdu.edu.cn+86 15318816220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026